Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation

J Clin Oncol. 2011 Mar 1;29(7):e169-70. doi: 10.1200/JCO.2010.31.8352. Epub 2010 Dec 13.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Biopsy, Needle
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / surgery
  • Follow-Up Studies
  • Gefitinib
  • Humans
  • Immunohistochemistry
  • Lower Extremity
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery
  • Male
  • Middle Aged
  • Necrosis / chemically induced
  • Necrosis / drug therapy
  • Neoplasm Invasiveness / pathology
  • Neoplasm Staging
  • Prednisolone / administration & dosage
  • Quinazolines / adverse effects*
  • Quinazolines / therapeutic use
  • Risk Assessment
  • Skin Diseases, Vascular / chemically induced*
  • Skin Diseases, Vascular / drug therapy
  • Skin Diseases, Vascular / pathology
  • Treatment Outcome
  • Vasculitis / chemically induced*
  • Vasculitis / drug therapy
  • Vasculitis / pathology

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Prednisolone
  • Gefitinib